Follicle Stimulating Hormone Market Size Share Growth

The Business Research Company’s Follicle Stimulating Hormone Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Follicle Stimulating Hormone Global Market Report 2023 evaluates follicle stimulating hormone market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12486&type=smp

The global follicle stimulating hormone market is expected to grow from $1.83 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The follicle stimulating hormone market is expected to reach $2.36 billion in 2027 at a CAGR of 5%.

The increasing prevalence of infertility is expected to propel the growth of the follicle-stimulating hormone market. Infertility is a condition affecting the male or female reproductive system that is indicated by the inability to conceive after 12 months or longer of frequent, unprotected sexual contact. Follicle-stimulating hormone encourages the development of eggs in the ovaries and aids in regulating the menstrual cycle in females. It promotes testicular growth in men and aids in producing a protein essential for male fertility by promoting the development of healthy sperm cells. For instance, in April 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, infertility affected around 1 in 6 adults worldwide, or about 17.5% of the adult population. Furthermore, in January 2020, according to the United Nations (UN), a US-based intergovernmental organization, it is anticipated that the current worldwide fertility rate of 2.5 live births per woman will decrease further to 2.2 in 2050 and then to 1.9 in 2100. Therefore, the increasing prevalence of infertility is driving the growth of the follicle-stimulating hormone market.

 Get More Information On The Follicle Stimulating Hormone Market Report:

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

The follicle stimulating hormone market segments in the report are:

1) By ype: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

The table of contents in TBRC’s follicle stimulating hormone market report includes:

1. Executive Summary
2. Follicle Stimulating Hormone Market Characteristics
3. Follicle Stimulating Hormone Market Trends And Strategies
4. Follicle Stimulating Hormone Market – Macro Economic Scenario
5. Follicle Stimulating Hormone Market Segmentation.

.

.

32. Global Follicle Stimulating Hormone Market Competitive Benchmarking
33. Global Follicle Stimulating Hormone Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market
35. Follicle Stimulating Hormone Market Future Outlook and Potential Analysis

 Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model